TRCT
TNYA icon

Tower Research Capital (TRC)’s Tenaya Therapeutics TNYA Stock Holding History

Tower Research Capital (TRC)’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$566 Buy
+817
New +$603 ﹤0.01% 4837
2025
Q3 		– Sell
-25,580
Closed -$15.6K – 5635
2025
Q2 		$15.6K Buy
25,580
+2,850
+13% +$1.45K ﹤0.01% 3807
2025
Q1 		$13K Buy
22,730
+10,328
+83% +$10.2K ﹤0.01% 3409
2024
Q4 		$17.7K Buy
12,402
+7,138
+136% +$16K ﹤0.01% 3289
2024
Q3 		$10.2K Sell
5,264
-10,330
-66% -$29.2K ﹤0.01% 3792
2024
Q2 		$48.3K Buy
15,594
+13,346
+594% +$55.1K ﹤0.01% 3125
2024
Q1 		$11.8K Sell
2,248
-3,076
-58% -$14.7K ﹤0.01% 3535
2023
Q4 		$17.3K Sell
5,324
-7,567
-59% -$16.3K ﹤0.01% 3747
2023
Q3 		$32.9K Buy
12,891
+7,986
+163% +$33.4K ﹤0.01% 2948
2023
Q2 		$28.8K Buy
4,905
+2,394
+95% +$13.9K ﹤0.01% 3063
2023
Q1 		$7K Sell
2,511
-3,709
-60% -$10.4K ﹤0.01% 4776
2022
Q4 		$12K Sell
6,220
-1,722
-22% -$4.2K ﹤0.01% 3752
2022
Q3 		$23K Buy
7,942
+5,200
+190% +$24.3K ﹤0.01% 3827
2022
Q2 		$15K Buy
2,742
+1,754
+178% +$14.2K ﹤0.01% 4093
2022
Q1 		$12K Sell
988
-1,156
-54% -$14K ﹤0.01% 4102
2021
Q4 		$41K Buy
2,144
+1,665
+348% +$36.3K ﹤0.01% 2927
2021
Q3 		$10K Buy
+479
New +$10.3K ﹤0.01% 4337

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tower Research Capital (TRC)'s TNYA Position: Q1 2026 in Review

Tower Research Capital (TRC) opened a new position in Tenaya Therapeutics (TNYA) in Q1 2026: 817 shares worth $566. The stake represents ﹤0.01% of the portfolio and ranks #4837 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in TNYA as recently as Q2 2025.

Tower Research Capital (TRC) first reported a position in TNYA in Q3 2021 and has held it in 17 quarters since. The position peaked at $48.3K in Q2 2024. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Tower Research Capital (TRC) held 817 shares of Tenaya Therapeutics worth $566 as of Q1 2026.
  • Tenaya Therapeutics was a new Tower Research Capital (TRC) position in Q1 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4837 holding.
  • Tower Research Capital (TRC) first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 17 quarters since.
  • Tower Research Capital (TRC)'s Tenaya Therapeutics position peaked at $48.3K in Q2 2024.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.